INDP - Indaptus Therapeutics, Inc.
0.825
0.015 1.818%
Share volume: 14,481
Last Updated: 03-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.81
0.01
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-08-2024 | 08-12-2024 | 11-12-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 3.943 M | 4.109 M | 3.142 M | |
| Selling general and admin | 2.352 M | 2.395 M | 1.676 M | |
| Research and development | 1.591 M | 1.714 M | 1.466 M | |
| Total expenses | 3.943 M | 4.109 M | 3.142 M | |
| 4.20% | -23.53% | |||
| Operating income | -3.943 M | -4.109 M | -3.142 M | |
| Ebit | -3.807 M | -4.015 M | -3.069 M | |
| Pretax income | -3.807 M | -4.015 M | -3.069 M | |
| 5.48% | -23.57% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -3.807 M | -4.015 M | -3.069 M | |
| -5.48% | 23.57% |